Nagaileben Co., Ltd. Stock

Equities

7447

JP3647000003

Medical Equipment, Supplies & Distribution

Market Closed - Japan Exchange 02:00:00 2024-04-19 am EDT 5-day change 1st Jan Change
2,276 JPY -1.56% Intraday chart for Nagaileben Co., Ltd. -4.85% -4.45%
Sales 2024 * 17.2B 111M Sales 2025 * 17.8B 115M Capitalization 72.43B 468M
Net income 2024 * 3.1B 20.04M Net income 2025 * 3.2B 20.68M EV / Sales 2024 * 4.21 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 4.07 x
P/E ratio 2024 *
23.4 x
P/E ratio 2025 *
22.6 x
Employees 511
Yield 2024 *
2.64%
Yield 2025 *
2.64%
Free-Float 59.37%
More Fundamentals * Assessed data
Dynamic Chart
Nagaileben Co., Ltd. announces an Equity Buyback for 500,000 shares, representing 1.57% for ¥1,000 million. CI
Nagaileben Co., Ltd. authorizes a Buyback Plan. CI
Nagaileben Co., Ltd. Provides Dividend Guidance for the Year Ending August 2024 CI
Nagaileben Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending February 2024 and the Fiscal Year Ending August 2024 CI
Tranche Update on Nagaileben Co., Ltd.'s Equity Buyback Plan announced on June 29, 2023. CI
Nagaileben Co., Ltd.'s Equity Buyback announced on June 29, 2023, has expired with 454,300 shares, representing 1.41% for ¥999.81 million. CI
Tranche Update on Nagaileben Co., Ltd.'s Equity Buyback Plan announced on June 29, 2023. CI
Nagaileben Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending Feb. 2024 and the Fiscal Year Ending August 2024 CI
Nagaileben Co., Ltd. Announces Dividend for the Year Ended August 2023; Payable on November 27, 2023; Provides Dividend Guidance for the Year Ending August 2024 CI
Tranche Update on Nagaileben Co., Ltd.'s Equity Buyback Plan announced on June 29, 2023. CI
Nagaileben Co., Ltd. announces an Equity Buyback for 500,000 shares, representing 1.55% for ¥1,000 million. CI
Nagaileben Co., Ltd. authorizes a Buyback Plan. CI
Nagaileben Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending August 31, 2023 CI
Nagaileben Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending February 2023 and Full Year Ending August 2023 CI
Nagaileben Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending August 31, 2023 CI
More news
1 day-1.56%
1 week-4.85%
Current month-4.37%
1 month-3.11%
3 months-5.95%
6 months+11.19%
Current year-4.45%
More quotes
1 week
2 249.00
Extreme 2249
2 406.00
1 month
2 233.00
Extreme 2233
2 516.00
Current year
2 186.00
Extreme 2186
2 542.00
1 year
1 974.00
Extreme 1974
2 542.00
3 years
1 796.00
Extreme 1796
2 818.00
5 years
1 796.00
Extreme 1796
3 115.00
10 years
1 740.00
Extreme 1740
3 225.00
More quotes
Managers TitleAgeSince
President 67 80-03-31
Chief Administrative Officer 51 19-06-30
Chief Operating Officer 67 08-11-30
Members of the board TitleAgeSince
President 67 80-03-31
Director/Board Member 62 92-04-30
Director/Board Member 73 92-10-31
More insiders
Date Price Change Volume
24-04-19 2,276 -1.56% 33,200
24-04-18 2,312 +1.14% 20,100
24-04-17 2,286 -3.58% 30,900
24-04-16 2,371 -0.92% 32,800
24-04-15 2,393 +0.04% 24,500

Delayed Quote Japan Exchange, April 19, 2024 at 02:00 am EDT

More quotes
NAGAILEBEN Co., Ltd. is a Japan-based company mainly engaged in the medical wear business. The Company operates medical wear business. The medical wear business purchases and sells medical wear products used by medical professionals and care workers from subsidiaries. In addition, the Company is also engaged in the sale of shoes and other products.
More about the company
Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
1
Last Close Price
2,276 JPY
Average target price
2,000 JPY
Spread / Average Target
-12.13%
Consensus